Diversity in Clinical Trials

MHP and RPM to democratize access to trials and increase diversity access for clinical trials and care.

Moderator: Taren Grom

 

Panelists

  • Tami Klerr, Executive VP and Chief Business Development & Marketing Officer, PRA Health Sciences, 2012 PharmaVOICE 100

  • Kent Thoelke, Executive Vice President and Chief Scientific Officer, PRA Health Sciences, 2013 PharmaVOICE 100

  • Elizabeth Garner, MD, Chief Medical Officer, ObsEva, 2019 PharmaVOICE 100

  • Jessica Scott, MD, JD, Head of R&D Patient Engagement Office, Takeda Pharmaceutical Company, 2020 PharmaVOICE 100

 RECORDING 

SPONSOR

CONTACT /

WHEN /

WHERE /

September 10, 2020

12:00am-11:59pm EDT

pharmavoice100.com

© 2020 by PharmaVOICE

Feedback2.png